| GILD |
Gilead Sciences, Inc. |
139.54B |
8.72% |
|
|
|
|
|
112.05 |
0.23% |
35.65% |
78.34% |
|---|
| AMGN |
Amgen Inc. |
167.37B |
7.97% |
|
|
|
|
|
311.55 |
1.50% |
34.22% |
40.80% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
7.63% |
|
|
|
|
|
634.23 |
-0.49% |
42.98% |
86.44% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
124.50B |
7.49% |
|
|
|
|
|
484.82 |
-1.60% |
29.36% |
31.63% |
|---|
| AZN |
AstraZeneca PLC |
227.94B |
3.83% |
|
|
|
|
|
73.50 |
-0.39% |
28.91% |
77.90% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
35.12B |
3.04% |
|
|
|
|
|
270.02 |
0.58% |
41.52% |
28.67% |
|---|
| BIIB |
Biogen Inc. |
20.03B |
2.19% |
|
|
|
|
|
136.84 |
-1.11% |
40.91% |
60.79% |
|---|
| ILMN |
Illumina, Inc. |
12.57B |
2.13% |
|
|
|
|
|
79.34 |
-0.83% |
49.78% |
52.90% |
|---|
| ARGX |
argenx SE |
35.96B |
2.00% |
|
|
|
|
|
591.87 |
0.46% |
31.77% |
33.40% |
|---|
| UTHR |
United Therapeutics Corporation |
13.85B |
1.59% |
|
|
|
|
|
308.27 |
0.42% |
35.09% |
86.28% |
|---|
| MRNA |
Moderna, Inc. |
10.94B |
1.53% |
|
|
|
|
|
28.35 |
-8.90% |
69.99% |
64.89% |
|---|
| VTRS |
Viatris Inc. |
10.40B |
1.48% |
|
|
|
|
|
8.71 |
0.35% |
30.87% |
74.07% |
|---|
| SNY |
Sanofi |
135.77B |
1.46% |
|
|
|
|
|
55.46 |
-0.64% |
31.16% |
64.76% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
11.03B |
1.40% |
|
|
|
|
|
110.60 |
-2.26% |
34.71% |
25.33% |
|---|
| SMMT |
Summit Therapeutics Inc. |
14.23B |
1.33% |
|
|
|
|
|
19.29 |
-5.07% |
47.52% |
13.25% |
|---|
| INCY |
Incyte Corporation |
11.72B |
1.32% |
|
|
|
|
|
60.55 |
-0.08% |
42.37% |
41.87% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.49B |
1.26% |
|
|
|
|
|
70.69 |
-1.05% |
33.04% |
33.98% |
|---|
| INSM |
Insmed Incorporated |
13.81B |
1.24% |
|
|
|
|
|
76.29 |
-2.18% |
46.27% |
4.86% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
6.19B |
1.15% |
|
|
|
|
|
63.82 |
-9.36% |
60.76% |
26.18% |
|---|
| RPRX |
Royalty Pharma plc |
13.49B |
1.13% |
|
|
|
|
|
31.13 |
-0.77% |
31.94% |
70.39% |
|---|
| BNTX |
BioNTech SE |
21.85B |
1.11% |
|
|
|
|
|
91.06 |
-4.10% |
45.15% |
67.24% |
|---|
| MEDP |
Medpace Holdings, Inc. |
9.28B |
1.05% |
|
|
|
|
|
304.69 |
-2.46% |
56.20% |
49.00% |
|---|
| PCVX |
Vaxcyte, Inc. |
4.86B |
1.00% |
|
|
|
|
|
37.76 |
-45.64% |
62.20% |
48.05% |
|---|
| EXEL |
Exelixis, Inc. |
10.33B |
0.96% |
|
|
|
|
|
36.92 |
0.60% |
35.76% |
38.73% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
14.05B |
0.89% |
|
|
|
|
|
131.92 |
0.08% |
11.93% |
1.31% |
|---|
| ROIV |
Roivant Sciences Ltd. |
7.20B |
0.85% |
|
|
|
|
|
10.09 |
-2.79% |
32.36% |
58.64% |
|---|
| ASND |
Ascendis Pharma A/S |
9.33B |
0.82% |
|
|
|
|
|
155.86 |
0.76% |
44.73% |
21.95% |
|---|
| BGNE |
BeiGene Ltd ADR |
|
0.80% |
|
|
|
|
|
|
|
|
|
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.54B |
0.75% |
|
|
|
|
|
124.15 |
1.00% |
31.17% |
61.21% |
|---|
| RVMD |
Revolution Medicines, Inc. |
6.57B |
0.74% |
|
|
|
|
|
35.36 |
-5.33% |
66.81% |
37.66% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
7.31B |
0.68% |
|
|
|
|
|
331.23 |
1.02% |
61.15% |
41.88% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.88B |
0.61% |
|
|
|
|
|
63.81 |
-0.05% |
37.56% |
25.13% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.66B |
0.56% |
|
|
|
|
|
88.51 |
-0.24% |
66.68% |
39.96% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
4.80B |
0.56% |
|
|
|
|
|
30.17 |
-3.15% |
57.02% |
76.32% |
|---|
| CYTK |
Cytokinetics, Incorporated |
4.76B |
0.55% |
|
|
|
|
|
40.19 |
-6.95% |
54.27% |
84.24% |
|---|
| TEM |
Tempus AI Inc |
|
0.53% |
|
|
|
|
|
|
|
|
|
|---|
| BBIO |
BridgeBio Pharma, Inc. |
6.57B |
0.53% |
|
|
|
|
|
34.57 |
-1.54% |
60.00% |
23.10% |
|---|
| NUVL |
Nuvalent, Inc. |
5.08B |
0.52% |
|
|
|
|
|
70.92 |
-2.92% |
47.10% |
49.00% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
3.12B |
0.48% |
|
|
|
|
|
33.54 |
-3.43% |
70.01% |
33.86% |
|---|
| ALKS |
Alkermes plc |
5.37B |
0.47% |
|
|
|
|
|
33.02 |
-0.57% |
55.46% |
59.42% |
|---|
| KRYS |
Krystal Biotech, Inc. |
5.19B |
0.45% |
|
|
|
|
|
180.30 |
-1.97% |
46.99% |
40.31% |
|---|
| ACLX |
Arcellx, Inc. |
3.60B |
0.42% |
|
|
|
|
|
65.60 |
-3.47% |
46.12% |
31.19% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
5.69B |
0.42% |
|
|
|
|
|
116.63 |
-1.60% |
49.12% |
15.02% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
3.04B |
0.41% |
|
|
|
|
|
32.15 |
-2.10% |
62.30% |
22.87% |
|---|
| ADMA |
ADMA Biologics, Inc. |
4.71B |
0.41% |
|
|
|
|
|
19.84 |
-2.07% |
61.47% |
23.31% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
2.75B |
0.40% |
|
|
|
|
|
21.87 |
-9.89% |
43.44% |
23.94% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
3.35B |
0.40% |
|
|
|
|
|
36.21 |
-4.26% |
71.90% |
34.14% |
|---|
| GH |
Guardant Health, Inc. |
5.26B |
0.37% |
|
|
|
|
|
42.60 |
-1.25% |
66.47% |
45.28% |
|---|
| IMVT |
Immunovant, Inc. |
2.90B |
0.36% |
|
|
|
|
|
17.09 |
-6.97% |
77.80% |
28.34% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.55B |
0.36% |
|
|
|
|
|
29.52 |
-6.58% |
67.15% |
27.99% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
4.02B |
0.35% |
|
|
|
|
|
50.96 |
-6.05% |
48.14% |
48.63% |
|---|
| CRSP |
CRISPR Therapeutics AG |
2.92B |
0.34% |
|
|
|
|
|
34.03 |
-8.00% |
52.17% |
49.24% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
3.35B |
0.34% |
|
|
|
|
|
52.97 |
-3.34% |
54.39% |
77.63% |
|---|
| VRNA |
Verona Pharma plc |
5.37B |
0.34% |
|
|
|
|
|
63.49 |
1.26% |
57.13% |
13.60% |
|---|
| ALVO |
Alvotech |
2.92B |
0.34% |
|
|
|
|
|
9.67 |
1.26% |
N/A |
N/A |
|---|
| NVCR |
NovoCure Limited |
1.96B |
0.33% |
|
|
|
|
|
17.82 |
-5.51% |
49.92% |
26.19% |
|---|
| VCYT |
Veracyte, Inc. |
2.31B |
0.31% |
|
|
|
|
|
29.65 |
-1.56% |
62.23% |
42.54% |
|---|
| DNLI |
Denali Therapeutics Inc. |
1.97B |
0.29% |
|
|
|
|
|
13.60 |
-8.02% |
64.25% |
63.21% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
2.57B |
0.29% |
|
|
|
|
|
33.55 |
-2.07% |
55.26% |
75.10% |
|---|
| MRUS |
Merus N.V. |
2.91B |
0.29% |
|
|
|
|
|
42.09 |
-5.65% |
47.93% |
22.76% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
2.51B |
0.29% |
|
|
|
|
|
8.16 |
-3.20% |
51.71% |
70.84% |
|---|
| TWST |
Twist Bioscience Corporation |
2.34B |
0.28% |
|
|
|
|
|
39.26 |
-2.73% |
66.71% |
39.71% |
|---|
| JANX |
Janux Therapeutics, Inc. |
1.60B |
0.28% |
|
|
|
|
|
27.00 |
-7.22% |
81.13% |
26.08% |
|---|
| VCEL |
Vericel Corporation |
2.24B |
0.28% |
|
|
|
|
|
44.62 |
0.27% |
58.27% |
75.11% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.77B |
0.28% |
|
|
|
|
|
16.61 |
-2.69% |
52.38% |
66.94% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.09B |
0.28% |
|
|
|
|
|
5.29 |
-8.95% |
72.85% |
7.84% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
2.09B |
0.27% |
|
|
|
|
|
22.00 |
-5.46% |
89.13% |
61.18% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
3.31B |
0.27% |
|
|
|
|
|
44.13 |
-6.92% |
95.98% |
50.64% |
|---|
| LEGN |
Legend Biotech Corporation |
3.12B |
0.26% |
|
|
|
|
|
33.93 |
-3.22% |
65.05% |
27.38% |
|---|
| VERA |
Vera Therapeutics, Inc. |
1.53B |
0.26% |
|
|
|
|
|
24.02 |
-9.80% |
65.71% |
67.43% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
1.78B |
0.26% |
|
|
|
|
|
27.37 |
-7.60% |
67.60% |
109.15% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.90B |
0.24% |
|
|
|
|
|
8.38 |
1.21% |
67.35% |
35.90% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
1.18B |
0.24% |
|
|
|
|
|
10.46 |
-8.65% |
230.48% |
49.37% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.25B |
0.24% |
|
|
|
|
|
20.47 |
-5.93% |
113.43% |
18.55% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
1.75B |
0.23% |
|
|
|
|
|
12.74 |
-7.81% |
56.04% |
63.20% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.97B |
0.23% |
|
|
|
|
|
48.36 |
-1.06% |
68.70% |
0.08% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
1.09B |
0.22% |
|
|
|
|
|
3.33 |
-6.46% |
74.66% |
43.14% |
|---|
| BEAM |
Beam Therapeutics Inc. |
1.95B |
0.22% |
|
|
|
|
|
19.53 |
-12.07% |
63.92% |
51.89% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
1.43B |
0.22% |
|
|
|
|
|
16.38 |
-3.93% |
142.62% |
66.71% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
2.14B |
0.21% |
|
|
|
|
|
51.37 |
-0.72% |
72.63% |
12.98% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.02B |
0.21% |
|
|
|
|
|
105.14 |
-2.30% |
51.23% |
81.97% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
2.22B |
0.20% |
|
|
|
|
|
37.36 |
-5.94% |
66.75% |
41.84% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
1.83B |
0.20% |
|
|
|
|
|
32.75 |
1.42% |
43.71% |
27.18% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
1.88B |
0.20% |
|
|
|
|
|
24.49 |
-7.31% |
102.73% |
34.44% |
|---|
| GERN |
Geron Corporation |
1.01B |
0.20% |
|
|
|
|
|
1.5900 |
-3.64% |
92.88% |
86.37% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
2.21B |
0.20% |
|
|
|
|
|
45.05 |
-2.04% |
49.91% |
51.95% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
3.22B |
0.20% |
|
|
|
|
|
40.48 |
-5.24% |
73.43% |
9.72% |
|---|
| WVE |
Wave Life Sciences Ltd. |
1.24B |
0.20% |
|
|
|
|
|
8.08 |
-6.26% |
317.00% |
18.80% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.90B |
0.19% |
|
|
|
|
|
33.19 |
0.00% |
54.28% |
46.61% |
|---|
| IBRX |
ImmunityBio, Inc. |
2.57B |
0.19% |
|
|
|
|
|
3.01 |
-4.14% |
162.94% |
31.11% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
1.68B |
0.19% |
|
|
|
|
|
29.30 |
-3.24% |
67.83% |
42.95% |
|---|
| IRON |
Disc Medicine, Inc. |
1.72B |
0.19% |
|
|
|
|
|
49.64 |
-5.19% |
76.09% |
30.25% |
|---|
| MNKD |
MannKind Corporation |
1.53B |
0.19% |
|
|
|
|
|
5.03 |
0.00% |
67.81% |
39.27% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
161.98M |
0.18% |
|
|
|
|
|
1.0000 |
-2.91% |
105.51% |
52.82% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
1.38B |
0.18% |
|
|
|
|
|
28.99 |
1.97% |
55.34% |
37.00% |
|---|
| FTRE |
Fortrea Holdings Inc. |
681.01M |
0.17% |
|
|
|
|
|
7.55 |
-5.98% |
63.01% |
106.84% |
|---|
| GPCR |
Structure Therapeutics Inc. |
330.54M |
0.17% |
|
|
|
|
|
17.31 |
-12.44% |
82.10% |
42.31% |
|---|
| DVAX |
Dynavax Technologies Corporation |
1.61B |
0.17% |
|
|
|
|
|
12.97 |
-5.19% |
247.79% |
46.95% |
|---|
| INDV |
Indivior PLC |
1.19B |
0.17% |
|
|
|
|
|
9.53 |
-0.31% |
108.09% |
70.76% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
1.86B |
0.17% |
|
|
|
|
|
15.64 |
-0.57% |
80.40% |
43.07% |
|---|